<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01208584</url>
  </required_header>
  <id_info>
    <org_study_id>306/09</org_study_id>
    <nct_id>NCT01208584</nct_id>
  </id_info>
  <brief_title>Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions</brief_title>
  <official_title>Brain Function and White Matter Changes in Congenital, Acute and Chronic Spinal Cord Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to use functional MRI (fMRI) and magnetic resonance (MR)&#xD;
      diffusion tensor imaging (DTI) to investigate brain activation and white matter changes in&#xD;
      patients with congenital (birth defect of the spinal column), acute and chronic complete&#xD;
      spinal cord lesions. The findings of this study may provide a basis to better understand the&#xD;
      pathomechanisms underlying the dynamic neurofunctional changes following a spinal cord&#xD;
      lesions in man. This understanding is important for the improvement of existing therapies and&#xD;
      for the development of new therapeutic approaches.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recently new approaches to spinal cord repair have been successfully established in animal&#xD;
      models. Promising therapies for promoting spinal axonal regeneration in man will be available&#xD;
      in the near future. Most research in the field is focussed on the lesion itself and the&#xD;
      perilesional spinal cord. The recovery of motor and sensory function is,however, not&#xD;
      permitted by local processes at the spinal level only. The whole central nervous system (CNS)&#xD;
      reacts to such a condition. Therefore the modulation of motor and sensory function in spinal&#xD;
      cord lesioned patients should be reflected in characteristic changes of cortical brain&#xD;
      activity, which are accessible to new non-invasive functional neuroimaging techniques such as&#xD;
      functional magnetic resonance imaging (fMRI). Changes of white matter due to axonal damage&#xD;
      can also be measured qualitatively and quantitatively using MR diffusion tensor imaging&#xD;
      (DTI). Those measures may provide a basis to better understand the pathophysiology underlying&#xD;
      spinal cord lesions in man, including changes in brain function over time (during&#xD;
      rehabilitation) or related to specific treatment. However, there are no studies available yet&#xD;
      addressing those topics or providing mechanism-based approaches for determining the time&#xD;
      interval of application of novel neuroregenerative drugs. By investigation of brain&#xD;
      activation and white matter changes in patients with congenital(myelomeningocele (MMC)),&#xD;
      acute and chronic spinal cord lesions (ASIA A) first and fundamental work in this field will&#xD;
      be conducted in this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Paraplegia, Spinal</condition>
  <condition>Myelomeningocele</condition>
  <arm_group>
    <arm_group_label>Chronic posttraumatic paraplegia</arm_group_label>
    <description>Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A, spinal cord injury (SCI) 12-24 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acute posttraumatic paraplegia</arm_group_label>
    <description>Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A,SCI 2-6 months,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myelomeningocele patients</arm_group_label>
    <description>Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12) ASIA A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Volunteers</arm_group_label>
    <description>Volunteers without any neurological deficits</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fMRI, DTI</intervention_name>
    <description>functional magnetic resonance imaging (fMRI), MR diffusion tensor imaging (DTI)</description>
    <arm_group_label>Acute posttraumatic paraplegia</arm_group_label>
    <arm_group_label>Chronic posttraumatic paraplegia</arm_group_label>
    <arm_group_label>Myelomeningocele patients</arm_group_label>
    <arm_group_label>Volunteers</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  Paraplegic patients (Thoracic level of lesion Th1-Th12), ASIA A&#xD;
&#xD;
          -  Myelomeningocele patients (congenital paraplegia, thoracic level of lesion Th1-Th12)&#xD;
             ASIA A&#xD;
&#xD;
          -  Volunteers without any neurological deficits&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Paraplegic patients (Th1-Th12, ASIA A),&#xD;
&#xD;
          -  Myelomeningocele patients (Th1-Th12 ASIA A)&#xD;
&#xD;
          -  Acute SCI 2-6 months, chronic SCI 12-24 months&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Traumatic brain injury (TBI)&#xD;
&#xD;
          -  Neurological diseases other than spinal cord lesion&#xD;
&#xD;
          -  MRI incompatibility&#xD;
&#xD;
          -  Pressure sores&#xD;
&#xD;
          -  methicillin-resistant Staphylococcus aureus (MRSA)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Stippich, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basle - Department of Neuroradiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital, Basle (only study site!)</name>
      <address>
        <city>Basle</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>September 23, 2010</study_first_submitted>
  <study_first_submitted_qc>September 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2010</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional MRI,primary motor cortex,spinal cord injury</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paraplegia</mesh_term>
    <mesh_term>Meningomyelocele</mesh_term>
    <mesh_term>Spina Bifida Cystica</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

